$3.51
-0.07-1.96%
最終更新: Oct 14, 4:27 PM
$3.51
-0.07-1.96%
Benzinga
Benzinga
Benzinga
水曜日, 10 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Taysha Gene Therapies (TSHA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.10 | $-0.10 | $-0.09 |
| Actual | $-0.13 | $-0.12 | $-0.12 | $-0.09 |
| Surprise | -18.2% | -20.0% | -20.0% | 0.00% |
| Revenue | ||||
| Estimate | $618180 | $758330 | $1.9M | $1.4M |
| Actual | $0 | $0 | $5.5M | $0 |
| Surprise | -100.0% | -100.0% | +190.4% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.14 | $-0.15 |
| Revenue | ||||
| Consensus | $618180 | $1.3M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.13 | $-0.11 | -18.2 % |
| Q1 | May 6, 2026 | $-0.12 | $-0.10 | -20.0 % |
| Q4 | Mar 19, 2026 | $-0.12 | $-0.10 | -20.0 % |
| Q3 | Nov 4, 2025 | $-0.09 | $-0.09 | 0.00 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $0 | $618.18K | -100.0 % |
| Q1 | May 6, 2026 | $0 | $758.33K | -100.0 % |
| Q4 | Mar 19, 2026 | $5.49M | $1.89M | 190.4 % |
| Q3 | Nov 4, 2025 | $0 | $1.43M | -100.0 % |